The association between response rate, progression-free survival, and overall survival in relapsed/refractory chronic lymphocytic leukemia and mantle cell leukemia since the introduction/adoption of rituximab
收藏官方服务：
资源简介：
Systematic review protocol registration
创建时间：
2015-08-04
